Product References
CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition.
Frontiers in oncology
Yang L,Wu Z,Sun W,Luo P,Chen S,Chen Y,Yan W,Li Y,Wang C
Tue Nov 07 00:00:00 EST 2023
CCNDBP1, a Prognostic Marker Regulated by DNA Methylation, Inhibits Aggressive Behavior in Dedifferentiated Liposarcoma via Repressing Epithelial Mesenchymal Transition.
Frontiers in oncology
Yang L,Wu Z,Sun W,Luo P,Chen S,Chen Y,Yan W,Li Y,Wang C
Tue Nov 07 00:00:00 EST 2023
UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway.
Cancer management and research
Ye Y,Huang S,Wu Y
Fri Apr 08 00:00:00 EDT 2022
Ubiquitin-specific protease 22 enhances intestinal cell proliferation and tissue regeneration after intestinal ischemia reperfusion injury.
World journal of gastroenterology
Ji AL,Li T,Zu G,Feng DC,Li Y,Wang GZ,Yao JH,Tian XF
Thu Feb 21 00:00:00 EST 2019
Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARγ.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Zhang JR,Lu QB,Feng WB,Wang HP,Tang ZH,Cheng H,Du Q,Wang YB,Li KX,Sun HJ
Fri Jun 01 00:00:00 EDT 2018
Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARγ.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Zhang JR,Lu QB,Feng WB,Wang HP,Tang ZH,Cheng H,Du Q,Wang YB,Li KX,Sun HJ
Fri Jun 01 00:00:00 EDT 2018
LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.
Journal of cellular and molecular medicine
Liu Y,Wang LL,Chen S,Zong ZH,Guan X,Zhao Y
Wed Aug 01 00:00:00 EDT 2018
LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.
Journal of cellular and molecular medicine
Liu Y,Wang LL,Chen S,Zong ZH,Guan X,Zhao Y
Wed Aug 01 00:00:00 EDT 2018
LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.
Journal of cellular and molecular medicine
Liu Y,Wang LL,Chen S,Zong ZH,Guan X,Zhao Y
Wed Aug 01 00:00:00 EDT 2018
LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.
Journal of cellular and molecular medicine
Liu Y,Wang LL,Chen S,Zong ZH,Guan X,Zhao Y
Wed Aug 01 00:00:00 EDT 2018
Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo.
OncoTargets and therapy
Wang Y,Meng Y,Zhang S,Wu H,Yang D,Nie C,Hu Q
Mon Mar 21 00:00:00 EDT 2022
Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo.
OncoTargets and therapy
Wang Y,Meng Y,Zhang S,Wu H,Yang D,Nie C,Hu Q
Mon Mar 21 00:00:00 EDT 2022
HOXA5 is a tumor suppressor gene that is decreased in gastric cancer.
Oncology reports
Peng X,Zha L,Chen A,Wang Z
Sat Sep 01 00:00:00 EDT 2018
HOXA5 is a tumor suppressor gene that is decreased in gastric cancer.
Oncology reports
Peng X,Zha L,Chen A,Wang Z
Sat Sep 01 00:00:00 EDT 2018
Lithium chloride inhibits cell survival, overcomes drug resistance, and triggers apoptosis in multiple myeloma via activation of the Wnt/β-catenin pathway.
American journal of translational research
Yao R,Sun X,Xie Y,Liu L,Han D,Yao Y,Li H,Li Z,Xu K
Wed Sep 30 00:00:00 EDT 2020
Lithium chloride inhibits cell survival, overcomes drug resistance, and triggers apoptosis in multiple myeloma via activation of the Wnt/β-catenin pathway.
American journal of translational research
Yao R,Sun X,Xie Y,Liu L,Han D,Yao Y,Li H,Li Z,Xu K
Wed Sep 30 00:00:00 EDT 2020
Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.
Molecular medicine reports
Wang AL,Li Y,Zhao Q,Fan LQ
Fri Jun 01 00:00:00 EDT 2018
Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.
Molecular medicine reports
Wang AL,Li Y,Zhao Q,Fan LQ
Fri Jun 01 00:00:00 EDT 2018
Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer.
Oncology reports
Song H,Dong M,Zhou J,Sheng W,Li X,Gao W
Thu Mar 01 00:00:00 EST 2018
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.
Cancers
Chen YA,Tzeng DTW,Huang YP,Lin CJ,Lo UG,Wu CL,Lin H,Hsieh JT,Tang CH,Lai CH
Mon Dec 31 00:00:00 EST 2018
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.
Cancers
Chen YA,Tzeng DTW,Huang YP,Lin CJ,Lo UG,Wu CL,Lin H,Hsieh JT,Tang CH,Lai CH
Mon Dec 31 00:00:00 EST 2018
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.
Cancers
Chen YA,Tzeng DTW,Huang YP,Lin CJ,Lo UG,Wu CL,Lin H,Hsieh JT,Tang CH,Lai CH
Mon Dec 31 00:00:00 EST 2018
Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.
Cancers
Chen YA,Tzeng DTW,Huang YP,Lin CJ,Lo UG,Wu CL,Lin H,Hsieh JT,Tang CH,Lai CH
Mon Dec 31 00:00:00 EST 2018